Farmax India Limited

BSE: 590094
₹0.09
▼ -0.01 (-10.00%)
March 7, 2017 · BSE · bse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
27/100
Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
-33.3
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
Data unavailable.
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Ownership

1 of 2 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter

Value and momentum

0 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-10.0%
Low 0.0900 · High 0.0900
1W return
-18.2%
Low 0.0900 · High 0.1100
1M return
-25.0%
Low 0.0900 · High 0.1300
52W return
-59.1%
Low 0.0900 · High 0.2200
Lifetime High ₹180.6500 (Jan. 14, 2010)
Lifetime Low ₹0.0900 (Sept. 27, 2016)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
0.1
10D
0.1
20D
0.1
50D
0.1
100D
0.1
200D
0.1

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
99.4%
Month avg. delivery
88.1%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

0.09
Pivot
First resistance0.09
Second resistance0.09
Third resistance0.09
First support0.09
Second support0.09
Third support0.09
Day RSI30.5
Day MFI12.5
Day MACD-0.01
Day MACD signal-0.01

Beta

1M-2.13
3M-1.04
1Y0.99
3Y0.58

Price change analysis

↓ -25.0%
Over 1 Month
LowHigh
0.090.13
↓ -35.7%
Over 3 Months
LowHigh
0.090.15
↓ -10.0%
Over 6 Months
LowHigh
0.090.16
↓ -59.1%
Over 1 Year
LowHigh
0.090.22
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Data unavailable.

Shareholding pattern / Ownership

Shareholding summary

Dec 2016
  • Promoter37.89%
  • FII/FPI0.84%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 37.89% in Dec 2016 qtr

Historical fii holding

FII/FPI holdings were unchanged at 0.84% in Dec 2016 qtr

All shareholding details →

DateClientDealActionQuantityPriceExchange
25 Nov 2016 C N FOODS RPIVATE LIMITED Bulk Sell 2,600,000 0.1400 BSE
25 Nov 2016 KALPANA K V P Bulk Buy 2,903,199 0.1500 BSE
2 Dec 2014 ANKITKUMAR DINESHKUMAR RAVAL Bulk Sell 2,050,328 0.9600 BSE
2 Dec 2014 ANKITKUMAR DINESHKUMAR RAVAL Bulk Buy 2,086,744 0.9900 BSE
2 Dec 2014 SANJEEV GORWARA HUF Bulk Buy 2,100,461 0.9600 BSE
13 Dec 2011 BMD EXPORTS PRIVATE LIMITED Bulk Sell 4,850,000 1.8200 BSE
9 Dec 2011 BMD EXPORTS PRIVATE LIMITED Bulk Buy 4,850,000 2.0000 BSE
21 Sep 2011 REGENT FINANCE CORPORATION PRIVATE LIMITED Bulk Sell 1,279,847 2.5000 BSE
21 Sep 2011 LOTUS GLOBAL INVESTMENT LIMITED Bulk Buy 1,735,000 2.5000 BSE
27 May 2011 NOPEA CAPITAL SERVICES PVT. LTD. Bulk Buy 3,500,000 4.0700 BSE

All bulk and block deals →

Corporate Actions

Full history (8 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Farmax Retail (India) Limited to Farmax India Limited
22 Sep 2016OTHER Annual General Meeting (Book Closure Start Date Revised)
23 Sep 2015OTHER Annual General Meeting
18 Sep 2014OTHERAnnual General Meeting
18 Jul 2013OTHERAnnual General Meeting

All corporate actions →

Corporate Announcements

All 111 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
18 Jun 2020 Delisting Members of the Exchange are hereby notified that in terms of Regulations of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, Section 21A of the Securities Contract (Regulations) Act, 1956, Securities Contract (Regulations) Rules, 1957 and Bye-Laws of the Exchange, it has been decided to delist (withdraw the admission to dealings in) equity shares of Farmax India Limited (FARMAXIND) w.e.f. July 10, 2020 as per SEBI (Delisting of Equity Shares) Regulations, 2009.
2 Dec 2019 Public Announcement - Delisting Members of the Exchange are hereby informed that the Exchange on November 26, 2019 has issued public notice in the newspaper for proposed compulsory delisting of equity shares of the company, in term of Regulation 22 (3) of SEBI (Delisting of Equity shares) Regulation, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/common/Corporate Announcements).
29 Sep 2018 Shareholders meeting Farmax India Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 29, 2018
30 May 2018 Clarification - Financial Results The Exchange has sought clarification from Farmax India Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013. -2. Financial results not submitted as per Indian Accounting Standard. -3. Standalone Reconciliation of profit and loss not submitted -4. Standalone Reconciliation of Equity not submitted. The response of the Company is awaited.
29 May 2018 Financial Result Updates Farmax India Limited has submitted to the Exchange, the financial results for the period ended March 31, 2018.
29 May 2018 Outcome of Board Meeting Farmax India Limited has informed the Exchange regarding Board meeting held on May 29, 2018. Declaration of audited financials and audited report for the financial quarter and year ended 31.03.2018.
24 May 2018 Trading Window Farmax India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 FROM 24.05.2018 and will be opened 48 hours after declaration of results.
2 May 2018 Shareholders meeting Farmax India Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on April 30, 2018. Further, the company has informed the Exchange regarding voting results.
30 Apr 2018 Shareholders meeting Farmax India Limited has informed the Exchange regarding Proceedings of Court Convened General Meeting held on April 30, 2018
10 Apr 2018 Press Release Farmax India Limited has informed the Exchange regarding a press release dated April 10, 2018, titled "PRESS RELASE ON NOTICE OF EXTRA ORDINARY GENERAL MEETING FOR SALE OF ASSETS AND RECLASSIFICATION OF PROMOTERS".

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • Down 59.1% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Farmax India Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.